Published in Psychopharmacology (Berl) on December 15, 2013
Glia in the cytokine-mediated onset of depression: fine tuning the immune response. Front Cell Neurosci (2015) 0.79
Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters. PLoS One (2014) 0.77
Triple reuptake inhibitors as potential next-generation antidepressants: a new hope? Future Med Chem (2015) 0.75
Safety, pharmacokinetic, and positron emission tomography evaluation of serotonin and dopamine transporter occupancy following multiple-dose administration of the triple monoamine reuptake inhibitor BMS-820836. Psychopharmacology (Berl) (2014) 0.75
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 45.33
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab (1996) 9.49
Global burden of depressive disorders in the year 2000. Br J Psychiatry (2004) 9.25
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab (2003) 3.77
Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res (2012) 3.31
Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys (1997) 3.14
A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol (1984) 3.11
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry (2004) 2.00
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol (2006) 1.67
Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. J Psychiatr Res (2011) 1.57
Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry (2001) 1.47
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci (2007) 1.46
Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol Psychiatry (2007) 1.40
Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB. Eur J Nucl Med (2000) 1.38
Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab (2001) 1.32
Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol (2005) 1.23
Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry (2008) 1.19
Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol (2007) 1.14
Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology (Berl) (2002) 1.07
A dose-finding study of duloxetine based on serotonin transporter occupancy. Psychopharmacology (Berl) (2006) 1.00
Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention. Clin Pharmacol Ther (2012) 0.92
SEP-225289 serotonin and dopamine transporter occupancy: a PET study. J Nucl Med (2011) 0.91
Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage (1999) 0.90
Triple reuptake inhibitors: the next generation of antidepressants. Curr Neuropharmacol (2008) 0.90
[(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites. Synapse (2001) 0.90
Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry (2005) 0.88
Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity. Synapse (2012) 0.86
Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry (2003) 0.86
Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. Eur J Nucl Med Mol Imaging (2006) 0.81
Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats. Mol Imaging Biol (2008) 0.81
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor. Eur J Pharmacol (2008) 0.80
Modeling of receptor ligand data in PET and SPECT imaging: a review of major approaches. J Neuroimaging (2001) 0.77
In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter. Eur J Nucl Med Mol Imaging (2006) 0.77
Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain. Synapse (1998) 0.77
Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor. Bioorg Med Chem Lett (2011) 0.75
Safety, pharmacokinetic, and positron emission tomography evaluation of serotonin and dopamine transporter occupancy following multiple-dose administration of the triple monoamine reuptake inhibitor BMS-820836. Psychopharmacology (Berl) (2014) 0.75
A high-resolution map of active promoters in the human genome. Nature (2005) 24.35
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst (2004) 5.87
Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry (2006) 4.30
Superoxide flashes in single mitochondria. Cell (2008) 4.08
Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. J Clin Oncol (2005) 3.31
DNA sequence motifs for structure-specific recognition and separation of carbon nanotubes. Nature (2009) 3.23
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer. J Clin Oncol (2005) 3.22
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst (2005) 3.08
Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia. Am J Psychiatry (2008) 2.40
Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology (2008) 2.28
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med (2012) 2.25
An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J Clin Invest (2008) 2.19
miR-1 induces growth arrest and apoptosis in malignant mesothelioma. Chest (2013) 2.11
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma. Cancer (2003) 2.04
Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology (2003) 1.99
Smoking-induced ventral striatum dopamine release. Am J Psychiatry (2004) 1.92
Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One (2008) 1.91
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88
Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies. J Nucl Med (2009) 1.88
Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol (2006) 1.82
Prominent roles of the NorR and Fur regulators in the Escherichia coli transcriptional response to reactive nitrogen species. Proc Natl Acad Sci U S A (2004) 1.81
Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ Res (2010) 1.74
Enhanced visual motion perception in major depressive disorder. J Neurosci (2009) 1.71
Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men. Neuropsychopharmacology (2007) 1.70
Discovery of Fur binding site clusters in Escherichia coli by information theory models. Nucleic Acids Res (2007) 1.67
Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci (2006) 1.65
Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J Biol Chem (2007) 1.50
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimers Res Ther (2011) 1.43
Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol Psychiatry (2007) 1.40
Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci (2004) 1.38
Functional molecular ecological networks. MBio (2010) 1.37
Spatial correlations of laminar BOLD and CBV responses to rat whisker stimulation with neuronal activity localized by Fos expression. Magn Reson Med (2004) 1.35
Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarker. Acad Radiol (2010) 1.35
p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ Res (2002) 1.34
Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study. Am J Psychiatry (2010) 1.34
Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr (2008) 1.33
Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale (2011) 1.32
Imaging superoxide flash and metabolism-coupled mitochondrial permeability transition in living animals. Cell Res (2011) 1.32
The role of interleukin-1 in wound biology. Part II: In vivo and human translational studies. Anesth Analg (2010) 1.32
Superoxide flashes: early mitochondrial signals for oxidative stress-induced apoptosis. J Biol Chem (2011) 1.31
Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes. J Bacteriol (2006) 1.28
Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Arch Gen Psychiatry (2009) 1.25
The association of multiple interacting genes with specific phenotypes in rice using gene coexpression networks. Plant Physiol (2010) 1.25
Abnormal corpus callosum integrity in bipolar disorder: a diffusion tensor imaging study. Biol Psychiatry (2008) 1.24
Discrete surface Ricci flow. IEEE Trans Vis Comput Graph (2008) 1.23
Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm (2009) 1.23
Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol (2005) 1.23
Effects of tryptophan depletion on the performance of an iterated Prisoner's Dilemma game in healthy adults. Neuropsychopharmacology (2006) 1.22
H5N1 influenza virus pathogenesis in genetically diverse mice is mediated at the level of viral load. MBio (2011) 1.22
Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI. Psychopharmacology (Berl) (2006) 1.21
Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo. Microbiology (2002) 1.21
Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry (2010) 1.20
A high density consensus genetic map of tetraploid cotton that integrates multiple component maps through molecular marker redundancy check. PLoS One (2012) 1.20
Calcium gradients underlying cell migration. Curr Opin Cell Biol (2011) 1.19
Evolution of transcription regulatory genes is linked to niche specialization in the bacterial pathogen Streptococcus pyogenes. J Bacteriol (2005) 1.19
Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry (2008) 1.19
Molecular ecological network analyses. BMC Bioinformatics (2012) 1.19
Cardioprotection by CaMKII-deltaB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ Res (2009) 1.18
Role of streptococcal T antigens in superficial skin infection. J Bacteriol (2006) 1.18
Phylogenetic molecular ecological network of soil microbial communities in response to elevated CO2. MBio (2011) 1.18
Kissing and nanotunneling mediate intermitochondrial communication in the heart. Proc Natl Acad Sci U S A (2013) 1.18
The role of interleukin-1 in wound biology. Part I: Murine in silico and in vitro experimental analysis. Anesth Analg (2010) 1.16
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid. Clin Cancer Res (2004) 1.16
Laparoscopic liver resection and the learning curve: a 14-year, single-center experience. Surg Endosc (2014) 1.15
The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circ Res (2005) 1.15
Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. J Cereb Blood Flow Metab (2013) 1.12
Transient relationships among BOLD, CBV, and CBF changes in rat brain as detected by functional MRI. Magn Reson Med (2002) 1.11
Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot Cell (2007) 1.11
Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications. Clin Lung Cancer (2004) 1.11
Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction. J Pharmacol Exp Ther (2012) 1.11
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood (2003) 1.11
Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm (2008) 1.11
Perpendicular magnetic anisotropy induced by tetragonal distortion of FeCo alloy films grown on Pd(001). Phys Rev Lett (2006) 1.10
Central role of mitofusin 2 in autophagosome-lysosome fusion in cardiomyocytes. J Biol Chem (2012) 1.10
Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain. J Cereb Blood Flow Metab (2006) 1.10
Response to "A critical evaluation of cpYFP as a probe for superoxide". Free Radic Biol Med (2011) 1.09
High-resolution length sorting and purification of DNA-wrapped carbon nanotubes by size-exclusion chromatography. Anal Chem (2005) 1.08
Synergistic triggering of superoxide flashes by mitochondrial Ca2+ uniport and basal reactive oxygen species elevation. J Biol Chem (2013) 1.08
Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys (2007) 1.08
Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol Psychiatry (2010) 1.07
A quantitative genotype algorithm reflecting H5N1 Avian influenza niches. Bioinformatics (2007) 1.07
Diagnosis prevention and treatment for PICC-related upper extremity deep vein thrombosis in breast cancer patients. Asia Pac J Clin Oncol (2012) 1.07
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.07
Fluorescence efficiency of individual carbon nanotubes. Nano Lett (2007) 1.07
Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies. Bioorg Med Chem Lett (2005) 1.07
Whole-genome association study on tissue tropism phenotypes in group A Streptococcus. J Bacteriol (2011) 1.06
Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biol Psychiatry (2012) 1.06
Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab (2011) 1.05
Default-mode-like network activation in awake rodents. PLoS One (2011) 1.04
Superoxide flashes: elemental events of mitochondrial ROS signaling in the heart. J Mol Cell Cardiol (2012) 1.04
Characterization of the Shewanella oneidensis Fur gene: roles in iron and acid tolerance response. BMC Genomics (2008) 1.04
The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology (2013) 1.02
Genetic susceptibility to the delayed sequelae of neonatal respiratory syncytial virus infection is MHC dependent. J Immunol (2010) 1.02
Preventing postoperative abdominal adhesions in a rat model with PEG-PCL-PEG hydrogel. Int J Nanomedicine (2012) 1.02
Measurement of metabolic tumor volume: static versus dynamic FDG scans. EJNMMI Res (2011) 1.02
Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro. Int J Pharm (2009) 1.02